Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
Operating Expenses | 5,938 | 4,408 | 0 | 2,931 | 0 |
Operating Income | -5,938 | -4,408 | N/A | -2,931 | N/A |
Interest Expense | -4 | 3 | 0 | 0 | 0 |
Other Income | 680 | 936 | 0 | -208 | 0 |
Pre-tax Income | -5,254 | -3,475 | 0 | -3,138 | 0 |
Net Income Continuous | -5,254 | -3,475 | N/A | -3,138 | N/A |
Net Income | $-5,254 | $-3,475 | $N/A | $-3,138 | $N/A |
EPS Basic Total Ops | -89.00 | -59.40 | N/A | -54.40 | N/A |
EPS Basic Continuous Ops | -88.90 | -59.34 | N/A | -54.34 | N/A |
EPS Diluted Total Ops | -89.00 | -59.40 | N/A | -54.40 | N/A |
EPS Diluted Continuous Ops | -88.90 | -59.34 | N/A | -54.34 | N/A |
EBITDA(a) | $-5,910 | $-4,380 | $N/A | $-2,931 | $N/A |